from Reuters: Health News https://reut.rs/2DAOgOt
Tuesday, February 12, 2019
U.S. FDA panel recommends approval of Johnson & Johnson's depression drug
An advisory panel to the U.S. Food and Drug Administration on Tuesday recommended Johnson & Johnson's experimental nasal spray, which has a compound similar to often-abused ketamine, for patients suffering from depression.
from Reuters: Health News https://reut.rs/2DAOgOt
from Reuters: Health News https://reut.rs/2DAOgOt
Subscribe to:
Post Comments (Atom)
-
(Reuters Health) - More than half of heart failure patients who visit the emergency room don't receive prompt follow-up care, and a Cana...
-
WEIGHT LOSS supplements could help overweight or obese patients with the diet plans. You could lose weight and avoid weight gain by adding...
-
A U.S. appeals court on Wednesday declined a request by Johnson & Johnson for an temporary restraining order blocking sales of generic v...
No comments:
Post a Comment